Page 164 - A Magyar Szemorvostársaság 2023. évi kongresszusa - Tudományos program és előadáskivonatok
P. 164

Differential diagnostic challenges in a case of a rare, neuro-ophthalmological disease
               with atypical manifestation
                                                                                                    4
                                 1
                                                                     3
                                                                                  4
                                                       2
               Márton Edelmayer , Fanni Szabó-Jóföldi , Szilvia Vajda , Zsolt Mezei , Magdolna Simó ,
               Krisztina Knézy , Zoltán Zsolt Nagy
                              3
                                                  3
               1 Péterfy Hospital, Department of Ophthalmology, Budapest1
               2 Jahn Ferenc Hospital, Department of Ophthalmology, Budapest
               3 Semmelweis University Department of Ophthalmology, Budapest
               4 Semmelweis University Department of Neurology, Budapest
               Objective:  To  present  a  rare  neuro-ophthalmological  disease  and  the  related  differential
               diagnostics through a case study.
               Patient and Methods: The leading symptoms of the 35-year-old male patient were diplopia,
               painful  movement  of  the  right  eye,  subjective  visual  impairment  (VA:  1.0).  He  had  a  prior
               medical history of right knee arthritis, and confirmed HLA-B52 seropositivity. In addition to the
               basic ophthalmological examinations, the diagnostic tools were OCT, ophthalmic ultrasound,
               Hess diplopia chart, Goldmann perimetry, visual evoked potential (VEP), cranial-orbital CT and
               MRI, immunoserology, and liquor analysis.

               Results, follow-up: The OCT did not confirm a right sided disc edema, but the ophthalmoscopic
               image  showed  forward  bulging  of  the  entire  posterior  pole,  which  raised  suspicion  of  a
               retrobulbar space occupying lesion. The ultrasound described the widening of the sheet of the
               right optic nerve. The critical fusion frequency (CFF) was 35/44 Hz. The Goldmann-perimetry
               showed a slightly enlarged blind spot on the right eye. The Hess chart revealed an elevational
               deficit of the right eye. The CT of the skull gave a negative result, while the MRI of the orbit
               described optic neuritis with perifocal edema. There was a slight increase of protein levels in
               the  CSF.  The  VEP  examination  indicated  right-sided  prechiasmal  demyelination-like
               dysfunction. The immunserological test showed strong anti-MOG positivity.

               As a result, Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) with right optic
               neuritis  was  confirmed,  which  is  a  rare,  antibody-mediated,  autoimmune,  inflammatory,
               demyelinating disease of the CNS. As a response to systemic steroid and azathioprine, the
               inflammatory symptoms decreased. The side effects of the treatment - intraocular pressure
               increase and central serous retinal detachment - regressed by the reduction of the steroid
               dose, and pressure-lowering drops.

               Conclusion: The diagnosis of MOGAD is possible by the detection of anti-MOG antibodies in
               serum. In case of therapy-refractory, recurrent optic neuritis with atypical presentation, it must
               be  considered  in  ophthalmology  practice  and  separated  from  other  etiologies  in  order  to
               choose  optimal  therapy.  The  ophthalmologist  plays  a  key  role  in  establishing  the  correct
               diagnosis, since the initial manifestation of MOGAD is often isolated optic neuritis. In this case,
               the  diagnosis  was  delayed  by  the  atypical  symptom  presentation  and  the  misleading
               serodiagnostic  results.  Long-term  systemic  immunosuppressive  therapy  is  essential  in  the
               treatment of the disease and in the prevention of relapses.
   159   160   161   162   163   164   165   166   167   168   169